Evidence map›Paper›PMID 31114180›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2019

Clinical burden of illness among patients with severe eosinophilic COPD.

Hana Müllerová, Wilhelmine H Meeraus, Dmitry V Galkin, Frank C Albers, Sarah H Landis

Abstract readComparative Study
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Exacerbations and Healthcare Burden of COPD with Type 2 Inflammation: US Claims Analysis.International journal of chronic obstructive pulmonary disease · 2026
    Article
  3. The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.International journal of chronic obstructive pulmonary disease · 2025
    Review
  4. Article
  5. Article
  6. Nonalcoholic Fatty Liver Disease.Handbook of experimental pharmacology · 2022
    Review
  7. Article
  8. Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.International journal of chronic obstructive pulmonary disease · 2021
    Observational
  9. Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort.International journal of chronic obstructive pulmonary disease · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hana MüllerováRespiratory Epidemiology, GSK, Uxbridge, UK.
Wilhelmine H MeerausRespiratory Epidemiology, GSK, Uxbridge, UK.
Dmitry V GalkinRespiratory Medical Franchise, GSK, Uxbridge, NC, USA.
Frank C AlbersRespiratory Medical Franchise, GSK, Uxbridge, NC, USA.
Sarah H LandisRespiratory Epidemiology, GSK, Uxbridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cost of IllnessEosinophilsAdministration, InhalationAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsAgedAged, 80 and overBronchodilator AgentsDatabases, FactualDisease ProgressionDrug Therapy, CombinationEosinophiliaFemaleHumansMaleMiddle AgedAdrenal Cortex HormonesAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsMuscarinic Antagonistsacute exacerbationsburden of illnesseosinophilsmultiple-inhaler triple therapy

Identifiers

PMID31114180
PMCPMC6497493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.